Drug Shortage Report for APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE

Last updated on 2023-10-06 History
Report ID 185951
Drug Identification Number 02509423
Brand name APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Common or Proper name SITAGLIPTAN MALATE/METFORMIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 850MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60 BTL
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-03-03
Estimated end date 2023-10-06
Actual end date 2023-10-05
Shortage status Resolved
Updated date 2023-10-06
Company comments Product on allocation due to increased demand
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2023-10-06 French Compare
v22 2023-10-06 English Compare
v21 2023-09-28 French Compare
v20 2023-09-28 English Compare
v19 2023-09-01 French Compare
v18 2023-09-01 English Compare
v17 2023-08-12 French Compare
v16 2023-08-12 English Compare
v15 2023-08-08 French Compare
v14 2023-08-08 English Compare
v13 2023-07-27 French Compare
v12 2023-07-27 English Compare
v11 2023-06-29 French Compare
v10 2023-06-29 English Compare
v9 2023-05-12 French Compare
v8 2023-05-12 English Compare
v7 2023-04-21 French Compare
v6 2023-04-21 English Compare
v5 2023-03-30 French Compare
v4 2023-03-30 English Compare

Showing 1 to 20 of 23